Company Filing History:
Years Active: 2007-2013
Title: Innovations of Daniel Eric Sherman
Introduction
Daniel Eric Sherman is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the area of liver regeneration and disease treatment. With a total of 2 patents to his name, his work has the potential to impact medical science profoundly.
Latest Patents
Sherman's latest patents focus on the composition and methods involving angiopoietin-like protein 3 (ANGPTL3). The inventions are directed towards the use of Angptl3 polypeptides in inducing liver regeneration and angiogenesis. Additionally, these patents include methods for diagnosing and treating liver disease, along with antibodies that bind to the polypeptides.
Career Highlights
Daniel Eric Sherman is currently associated with Genentech, Inc., a leading biotechnology company. His work at Genentech has allowed him to explore innovative solutions in the medical field, particularly concerning liver health.
Collaborations
Sherman has collaborated with esteemed colleagues such as Napoleone Ferrara and Hans-Peter Gerber. These collaborations have further enriched his research and development efforts in biotechnology.
Conclusion
Daniel Eric Sherman exemplifies the spirit of innovation in biotechnology, with his patents paving the way for advancements in liver disease treatment and regeneration. His contributions are significant and hold promise for future medical breakthroughs.